Earning Preview: Ingredion Q2 revenue is expected to decrease by 2.90%, institutions lean positive on execution and mix

Earnings Agent
Jul 29

Abstract

Ingredion Incorporated will report results on August 04, 2026 Pre-Market; this preview compiles the latest quarterly forecasts and recent analyst sentiment to frame expectations for revenue, profitability, and mix trends.

Market Forecast

Consensus for the current quarter points to total revenue of 1.83 billion US dollars, an estimated year-over-year decrease of 2.90%, with EPS around 2.72, implying a 2.37% year-over-year decline; EBIT is projected at 240.26 million US dollars, implying a 9.82% year-over-year decline. Management’s mix strategy and prior commentary imply gross margin resilience near the recent 22.38% level and a net margin that may trend close to the recent 7.92%, though headline growth is expected to be softer; adjusted EPS is guided by the forecast above, with a modest year-over-year decline.

Main business momentum remains anchored in Texture & Healthful Solutions and stable sweeteners demand in Latin America, with a focus on higher-value texturizers and clean-label solutions supporting mix. The most promising segment is Texture & Healthful Solutions with recent quarterly revenue of 617.00 million US dollars and sustained volume expansion, where YoY growth signals are positive from prior disclosures even as broader volumes remain uneven.

Last Quarter Review

In the previous quarter, Ingredion delivered revenue of 1.79 billion US dollars, a gross profit margin of 22.38%, GAAP net profit attributable to shareholders of 142.00 million US dollars, a net margin of 7.92%, and adjusted EPS of 2.34, with year-over-year growth rates of approximately -1.16% for revenue and -21.21% for adjusted EPS. A notable operational highlight was EBIT of 212.00 million US dollars against consensus, with a shortfall versus expectations, reflecting softer volumes and cost headwinds relative to the prior year.

By business, Texture & Healthful Solutions generated 617.00 million US dollars, Food & Industrial Ingredients–Latin America 579.00 million US dollars, Food & Industrial Ingredients–U.S./Canada 475.00 million US dollars, and Other 121.00 million US dollars; the mix continued to tilt toward higher-value solutions, while certain sweetener categories saw uneven demand.

Current Quarter Outlook

Main business trajectory and revenue/EPS sensitivity

Revenue is projected at 1.83 billion US dollars, down 2.90% year over year, with EPS forecast at 2.72, down 2.37% year over year, and EBIT at 240.26 million US dollars, down 9.82% year over year. The margin framework suggests gross margin near the recent trend of 22.38% and net margin around recent levels, given continued mix improvement and disciplined pricing, though absolute volumes are not expected to accelerate meaningfully this quarter. The company’s ability to hold price/cost and maintain favorable product mix is the key swing factor for EPS, while limited top-line growth keeps leverage modest.

North America and Latin America sweeteners and starches underpin the base, with Food & Industrial Ingredients–U.S./Canada and –Latin America together representing roughly 1.05 billion US dollars last quarter. Sequential demand for certain end markets like brewing has been improving, but softness in confectionery and paper/corrugating has persisted, constraining top-line upside. Operating execution in large facilities is expected to be steady this quarter; any incremental improvement in throughput or logistics could support EBIT toward the top of the projected range.

Given the forecast declines in EBIT and EPS, investors will emphasize the bridge from revenue to profit: whether a stable gross margin near the low-20s can offset any residual volume pressure. If cost inputs remain benign and mix continues shifting to higher-value solutions, EPS could track close to the 2.72 forecast even if revenue is at the low end of the range.

Most promising business and mix-led growth drivers

Texture & Healthful Solutions remains the most promising growth engine, with last quarter revenue of 617.00 million US dollars and ongoing clean-label and texturizer demand. Industry feedback and company disclosures indicate sustained volume growth and robust customer reformulation activity, supporting a favorable margin profile relative to commodity sweeteners. This business benefits from a pipeline of higher-value solutions, including clean-label starches and specialty texturizers, which tend to be less cyclical and more price-resilient.

The emphasis on solutions selling, not just ingredients, allows cross-portfolio adoption and deeper customer integration, often enhancing price realization. In the current quarter, any incremental wins in reformulation tied to cost or supply challenges in adjacent inputs (e.g., cocoa/eggs in past periods) can amplify demand for texturizers and functional systems. As this mix expands, consolidated gross margin can hold or improve even if headline revenue is slightly down year over year, setting up a more constructive trajectory for the back half.

A secondary support comes from Latin America, where a pivot toward higher-margin sweeteners has historically helped offset volume variability. If Latin America maintains stable throughput and mix tilt, it can provide a cushion to consolidated EBIT despite top-line softness elsewhere.

Stock-price swing factors for this quarter

The first swing factor is the trajectory of gross margin relative to the recent 22.38% level; even a 50–100 basis point deviation can materially affect EPS given the modest revenue base. The second is operational execution, particularly in the larger North American network, where any improvement in production efficiency or inventory availability can narrow the gap between revenue and EBIT forecasts. The third is segment mix, with outperformance in Texture & Healthful Solutions translating into better consolidated profitability despite a flat-to-down revenue backdrop.

On the demand side, brewing and selected industrial end markets are showing signs of stabilization, while confectionery and paper/corrugating remain uneven; upside surprise would likely require faster normalization in these categories. Price/cost remains a watch item: if input costs remain benign and pricing sticks, net margin near the prior 7.92% becomes more defensible. Guidance tone around back-half volumes and the solutions pipeline will likely shape post-earnings sentiment more than small variances in the quarter’s revenue tally.

Analyst Opinions

The majority of recent opinions trend bullish, with buy-leaning views outweighing cautious takes. Oppenheimer maintained a Buy rating with a 126.00 US dollars price target, highlighting execution and favorable mix supported by Texture & Healthful Solutions. Recent coverage has also emphasized that Latin America’s product mix and momentum in clean-label texturizers provide a stabilizing backdrop for consolidated profitability despite softer top-line trends.

Bullish analysts point to the company’s solutions-led model and pricing discipline as drivers of resilient margins and cash generation, even as headline revenue dips 2.90% year over year this quarter. The focus is on the durability of demand for higher-value texturizers and clean-label offerings, which can support adjusted EPS around 2.72 and EBIT near 240.26 million US dollars, limiting downside risk if volumes remain tepid. The prevailing view expects management commentary to reinforce mix-led margin preservation and incremental recovery in select end markets into the back half, which would underpin a constructive stance on the shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10